Form D · Biotechnology
MarvelBiome, Inc.
Woburn, MA · CIK 0001815665
Offering snapshot reported Oct 22, 2025 · SEC filing
- Reported sold
- $39.6M Offering amount: $52.5M
- Investors reported
- 10 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 10, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 22, 2025 | Initial | $39,561,794 | No comparison | 10 | SEC filing |
| Aug 2, 2023 | Initial | $10,000,000 | No comparison | 1 | SEC filing |
| Nov 17, 2020 | Initial | $3,100,001 | No comparison | 6 | SEC filing |
| Jun 22, 2020 | Initial | $2,258,952 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-561688
Source: Form D, filed Oct 22, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Mukesh Chatter | Director |
| Priti Chatter | Director |
| J. Amaranath Govindan | Director, Executive |
| Jothi Amaranath Govindan | Director, Executive |
| G. Zachary Gund | Director |
| Elamparithi Jayamani | Executive |
| Gary Ruvkun | Director |
| Rudolph E. Tanzi | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
8 Cabot Road, Suite 3500
Woburn, MA, 01801
Woburn, MA, 01801